Catalyst

product on market Capsule Advocare 🟢 Safety: 100/100
Brand: Advocare
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 14% of ingredients have research evidence
B Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Capsule(s) Serving Size
30 Servings
Amino acid/Protein Product Type
14% Evidence Coverage

Supplement Facts — Evidence Check

1200 mg
📊 Market median: 420.0mg (227 products)
Median 420.0mg This product: 1200mg
450 mg
📊 Market median: 17.4mg (161 products)
Median 17.4mg This product: 450mg
225 mg
📊 Market median: 17.4mg (161 products)
Median 17.4mg This product: 225mg
L-Valine
225 mg
100 mg
📊 Market median: 500.0mg (143 products)
This product: 100mg
50 mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 50mg
50 mg
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 50mg

Other Ingredients

Gelatin Stearic Acid Magnesium Stearate Silicon Dioxide

Label Claims — Verification

❓ All Other
❓ Structure/Function
All Other (98% of products) Structure/Function (90% of products) Nutrient (52% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions for use: Take three capsules 30 minutes prior to a meal, workout or bedtime. Up to three servings may be taken per day.

⚠️ Warnings & Precautions

Note: If you are pregnant or nursing, check with your health care professional before using this product.

Keep out of reach of children

Additional Information

Made in USA

Catalyst also enhances strength and provides sustained energy during physical activity.

Informed-Choice.org Trusted by sport

Supports muscle tone Enhanced strength and energy

TRIM

T2010/03L1014

Product Details

DSLD Entry Date 2016-06-24
Product Type Amino acid/Protein
Form Capsule
Brand Advocare
DSLD ID 60518
Data Updated 2026-04-11

Research Evidence

40 Research Sources
54 Avg Quality Score
16 Rct
12 Meta Analysis
7 Clinical Trial
5 Systematic Review
A Glutamine supplementation for critically ill adults
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
B Glutamine for induction of remission in Crohn's disease
Systematic Review The Cochrane database of systematic reviews 2016
PubMed DOI Cochrane
B Human growth hormone and glutamine for patients with short bowel syndrome
Systematic Review The Cochrane database of systematic reviews 2010
PubMed DOI Cochrane
B Immunonutrition as an adjuvant therapy for burns
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI
B Glutamine supplementation to prevent morbidity and mortality in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2008
PubMed DOI Cochrane
B Glutamine supplementation to prevent morbidity and mortality in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI Cochrane
B Glutamine supplementation to prevent morbidity and mortality in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI Cochrane
B Glutamine supplementation for young infants with severe gastrointestinal disease
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
B Glutamine supplementation to prevent morbidity and mortality in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI Cochrane
View all evidence for Glutamine →

Compare Similar Products

Mindlinx Complex BioCare 100
Neurolink Designs for Health 100
GI Repair Nutrients Vital Nutrients 100
Gastro Support Kirkman 100
FloraMore Renew Life 100
View all Glutamine products →
Glutamine research & evidence Best Glutamine rankings All Glutamine products More from Advocare View on NIH DSLD →